Unknown

Dataset Information

0

Gardenia jasminoides protects against cerulein-induced acute pancreatitis.


ABSTRACT: AIM:To investigate the effect of Gardenia jasminoides (GJ) on cerulein-induced acute pancreatitis (AP) in mice. METHODS:C57BL/6 mice weighing 18-20 g were divided into three groups. (1) Normal saline-treated group, (2) treatment with GJ at a dose of 0.1 g/kg, (3) treatment with GJ at a dose of 1 g/kg. GJ was administered orally (n = 6 per group) for 1 wk. Three hours later, the mice were given an intraperitoneal injection of cerulein (50 microg/kg), a stable cholecystokinin (CCK) analogue, every hour for a total of 6 h as described previously. The mice were sacrificed at 6 h after completion of cerulein injections. Blood samples were obtained to determine serum amylase, lipase and cytokine levels. The pancreas was rapidly removed for morphologic examination and scoring. A portion of pancreas was stored at -70 degree and prepared for the measurement of tissue myeloperoxidase (MPO) activity, an indicator of neutrophil sequestration, and for reverse-transcriptase PCR (RT-PCR) and real-time PCR measurements. RESULTS:Treatment with GJ decreased significantly the severity of pancreatitis and pancreatitis-associated lung injury. Treatment with GJ attenuated the severity of AP compared with saline-treated mice, as shown by reduction in pancreatic edema, neutrophil infiltration, serum amylase and lipase levels, serum cytokine levels, and mRNA expression of multiple inflammatory mediators. CONCLUSION:These results suggest that GJ attenuated the severity of AP as well as pancreatitis-associated lung injury.

SUBMITTER: Jung WS 

PROVIDER: S-EPMC2761580 | biostudies-literature | 2008 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Aim</h4>To investigate the effect of Gardenia jasminoides (GJ) on cerulein-induced acute pancreatitis (AP) in mice.<h4>Methods</h4>C57BL/6 mice weighing 18-20 g were divided into three groups. (1) Normal saline-treated group, (2) treatment with GJ at a dose of 0.1 g/kg, (3) treatment with GJ at a dose of 1 g/kg. GJ was administered orally (n = 6 per group) for 1 wk. Three hours later, the mice were given an intraperitoneal injection of cerulein (50 microg/kg), a stable cholecystokinin (CCK)  ...[more]

Similar Datasets

| S-EPMC6458522 | biostudies-literature
| S-EPMC4272226 | biostudies-literature
2018-09-12 | GSE109227 | GEO
| S-EPMC3894737 | biostudies-literature
| S-EPMC7833168 | biostudies-literature
| S-EPMC3173207 | biostudies-literature
| S-EPMC3931685 | biostudies-literature
| S-EPMC4016516 | biostudies-literature